In addition, prophylactic CTSS inhibitor treatment reduced OVA-induced mucus obstruction in the airways [64] suggesting a possible therapeutic role for prophylactic CTSS inhibitor treatment in patients with asthma. This evidence concerns the gene CTSS and asthma.